BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23913169)

  • 1. Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease.
    Gucer H; Szentgyorgyi E; Ezzat S; Asa SL; Mete O
    Virchows Arch; 2013 Oct; 463(4):593-7. PubMed ID: 23913169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.
    Lubensky IA; Pack S; Ault D; Vortmeyer AO; Libutti SK; Choyke PL; Walther MM; Linehan WM; Zhuang Z
    Am J Pathol; 1998 Jul; 153(1):223-31. PubMed ID: 9665483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell neuroendocrine tumor of the pancreas in von Hippel-Lindau disease: a case report and literature review.
    Woo CG; Choi SY; Kwak JJ; Chin S; Kim HK
    Neuro Endocrinol Lett; 2017 May; 38(2):83-86. PubMed ID: 28650600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing clear cell neuroendocrine tumors on cytological specimens: Report of two cases and brief literature review.
    Buckley K; Li Z
    Diagn Cytopathol; 2017 Aug; 45(8):757-760. PubMed ID: 28387021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease].
    Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F
    Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic renal cell carcinoma versus pancreatic neuroendocrine tumor in von Hippel-Lindau disease: treatment with interleukin-2.
    Williams C; Walther M
    ScientificWorldJournal; 2005 Jan; 5():9-10. PubMed ID: 15674444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hereditary forms of pancreatic neuroendocrine tumors.
    DeLellis RA
    Adv Anat Pathol; 1999 May; 6(3):149-53. PubMed ID: 10342012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell carcinoid tumor of the gallbladder: another distinctive manifestation of von Hippel-Lindau disease.
    Sinkre PA; Murakata L; Rabin L; Hoang MP; Albores-Saavedra J
    Am J Surg Pathol; 2001 Oct; 25(10):1334-9. PubMed ID: 11688471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
    Corleto VD; Cotesta D; Petramala L; Panzuto F; Pagnini C; Masoni L; Verrienti A; Delle Fave G; Filetti S; Letizia C
    JOP; 2009 Sep; 10(5):562-5. PubMed ID: 19734639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma.
    Hoang MP; Amirkhan RH
    Am J Surg Pathol; 2003 Aug; 27(8):1152-6. PubMed ID: 12883249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
    Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.
    Tirosh A; Killian JK; Petersen D; Zhu YJ; Walker RL; Blau JE; Nilubol N; Patel D; Agarwal SK; Weinstein LS; Meltzer P; Kebebew E
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3285-94. PubMed ID: 32706863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
    Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
    Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
    Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
    Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian Steroid Cell Tumor in an Adolescent With Von Hippel-Lindau Syndrome: A Case Report and Review of the Literature.
    Marques A; Portugal R
    Int J Gynecol Pathol; 2020 Sep; 39(5):473-477. PubMed ID: 31433374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease.
    Tamura K; Nishimori I; Ito T; Yamasaki I; Igarashi H; Shuin T
    World J Gastroenterol; 2010 Sep; 16(36):4515-8. PubMed ID: 20857520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of pancreatic neuroendocrine neoplasmas in Von Hippel-Lindau syndrome].
    Liu WK; Tian XD; Yang YM
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):869-872. PubMed ID: 30392308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease.
    Hoang MP; Hruban RH; Albores-Saavedra J
    Am J Surg Pathol; 2001 May; 25(5):602-9. PubMed ID: 11342771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Von Hippel-Lindau disease type 2-related pancreatic neuroendocrine tumor and adrenal myelolipoma].
    Dolzhansky OV; Morozova MM; Korostelev SA; Kanivets IV; Chardarov NK; Shatveryan GA; Paltseva EM; Fedorov DN
    Arkh Patol; 2016; 78(1):36-41. PubMed ID: 26978235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.